School of Medicine


Showing 1-4 of 4 Results

  • Ramsudha Narala

    Ramsudha Narala

    Clinical Assistant Professor, Ophthalmology

    BioDr. Ramsudha Narala is a board certified ophthalmologist who specializes in vitreoretinal surgery and ocular oncology. Dr. Narala attended the 8 year combined undergraduate-medical school program at Saint Louis University in Saint Louis, Missouri. After medical school, she completed her ophthalmology residency at Kresge Eye Institute in Detroit, MI, where she received the best resident teacher award and highest resident ophthalmic knowledge assessment program exam score award. She then joined the University of Southern California in Los Angeles, California for a 2 year vitreoretinal surgery fellowship where she was elected chief vitreoretinal surgery fellow. Following completion of vitreoretinal surgery fellowship, she pursued an advanced training fellowship in ocular oncology at Byers Eye Institute at Stanford University.

    Dr. Narala has authored many peer-reviewed scientific publications and textbook chapters on vitreoretinal diseases and ocular oncology and has been invited to speak at many national conferences. She is also dedicated to education and teaching medical students, residents, and fellows. She serves on many academic committees and is one of the current associate program directors for the Stanford ophthalmology residency training program.

    Dr. Narala's clinical practice is mainly based at Santa Clara Valley Medical Center.

  • Quan Dong Nguyen, MD, MSc

    Quan Dong Nguyen, MD, MSc

    Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)

    Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.

    We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders.

  • Omondi Nyong'o

    Omondi Nyong'o

    Adjunct Clinical Instructor, Ophthalmology

    BioOmondi L. Nyong'o, M.D., is a pediatric ophthalmologist and Adjunct Clinical Instructor in Ophthalmology at the Stanford University School of Medicine. At Stanford, he teaches medical students in the introduction to the eye and instructs ophthalmology residents and fellows in strabismus surgery. He also leads philanthropic fundraising for collaborative pediatric amblyopia research at the Lucile Packard Children's Hospital Foundation. He is in private practice at NYONG'O - Institute for Pediatric Vision in Woodside and San Francisco.